AQST All goes well and as planned for the companyAQST all pull backs can be used as new buying opportunities.
FDA Type C Meeting
The Company also successfully completed a Type C meeting with the FDA that addressed open items from the November 2022 End-of-Phase 2 meeting including addressing (1) the impact of any product hold time, (2) the potenti